Retrieve to Explain: Evidence-driven Predictions for Explainable Drug Target Identification
This addresses the need for explainable AI in drug target identification, a high-stakes domain where failures are costly, though it is incremental as it builds on retrieval and attribution methods.
The authors tackled the problem of quantitatively comparing plausible answers to scientific questions by introducing Retrieve to Explain (R2E), a retrieval-based model that scores answers based on evidence, and applied it to drug target identification, where it matched non-explainable literature-based models and surpassed a genetics-based industry approach.
Language models hold incredible promise for enabling scientific discovery by synthesizing massive research corpora. Many complex scientific research questions have multiple plausible answers, each supported by evidence of varying strength. However, existing language models lack the capability to quantitatively and faithfully compare answer plausibility in terms of supporting evidence. To address this, we introduce Retrieve to Explain (R2E), a retrieval-based model that scores and ranks all possible answers to a research question based on evidence retrieved from a document corpus. The architecture represents each answer only in terms of its supporting evidence, with the answer itself masked. This allows us to extend feature attribution methods such as Shapley values, to transparently attribute answer scores to supporting evidence at inference time. The architecture also allows incorporation of new evidence without retraining, including non-textual data modalities templated into natural language. We developed R2E for the challenging scientific discovery task of drug target identification, a human-in-the-loop process where failures are extremely costly and explainability paramount. When predicting whether drug targets will subsequently be confirmed as efficacious in clinical trials, R2E not only matches non-explainable literature-based models but also surpasses a genetics-based target identification approach used throughout the pharmaceutical industry.